Results 161 to 170 of about 32,698 (277)

Epistaxis and thrombocytopenia as major presentations of louse borne relapsing fever: Hospital-based study. [PDF]

PLoS One, 2022
Abera EG, Tukeni KN, Didu GH, Chala TK, Yilma D, Gudina EK.   +5 more
europepmc   +1 more source

Infection control in the brain and the eye

Acta Ophthalmologica, EarlyView.
Abstract The Central Nervous System (CNS), comprising the brain and the eye, is considered to have a ‘privileged’ mechanism for dealing with immunological challenge (immune privilege, IP). CNS IP has been revealed through experiments using foreign protein antigens and cell and tissue alloantigens (grafts), but evidence for a role for IP in modulating ...
John V. Forrester, Paul G. McMenamin, Samantha J. Dando   +2 more
wiley   +1 more source

A Novel Relapsing Fever Group Borrelia Isolated from Ornithodoros Ticks of the Brazilian Caatinga. [PDF]

Microorganisms, 2023
Oliveira GMB, Muñoz-Leal S, Santodomingo A, Weck BC, Faccini-Martínez ÁA, Horta MC, Labruna MB.   +6 more
europepmc   +1 more source

Tick-Borne Relapsing Fever, Southern Spain, 2004–2015

Emerging Infectious Diseases, 2016
Luis Castilla-Guerra, Jorge Marín-Martín, Miguel Angel Colmenero-Camacho   +2 more
doaj   +1 more source

Editorial Note: Detection of relapsing fever Borrelia spp., Bartonella spp. and Anaplasmataceae bacteria in argasid ticks in Algeria. [PDF]

PLoS Negl Trop Dis
PLOS Neglected Tropical Diseases Editors.
europepmc   +1 more source

Melioidosis in companion animals: Analysis of 45 Australian cases (24 dogs; 21 cats) from 1997 to 2025 and a brief review of the animal and human literature

Australian Veterinary Journal, EarlyView.
Objective To report 45 cases of melioidosis in dogs and cats from northern Australia and analyse trends in epidemiology, clinical presentation, pathogenesis and response to treatment over a 27‐year period. Design Retrospective and prospective analysis of clinical records.
K Lee, C Shilton, S Benedict, M Krockenberger, M Mayo, BJ Currie, R Malik   +6 more
wiley   +1 more source

Louse-borne relapsing fever in Ethiopia: an urgent call for WHO recognition as a neglected tropical disease. [PDF]

BMJ Glob Health
Arega B, Mersha A, Zeleke A, Tafesse B, Melaku Y, Regassa A, Abiyo M, Liyew E, Samuel K, Tesfaye B, Agunie A.   +10 more
europepmc   +1 more source

Case Report: Exposure to Relapsing Fever Group Borreliae in Patients with Undifferentiated Febrile Illness in Mexico. [PDF]

Am J Trop Med Hyg, 2023
Vázquez-Guerrero E, Gordillo-Pérez G, Ríos-Sarabia N, Lopez JE, Ibarra JA.   +4 more
europepmc   +1 more source

The relapse in scarlet fever [PDF]

Archives of Disease in Childhood, 1934
openaire   +2 more sources

Real‐world treatment patterns and outcomes in accelerated and blast‐phase myeloproliferative neoplasms: Insights from a large multi‐centre cohort analysis in the United Kingdom

British Journal of Haematology, EarlyView.
Summary This UK‐based retrospective analysis describes real‐world treatment patterns and outcomes in 175 patients with accelerated (AP, n = 69) or blast‐phase (BP, n = 106) ‘Philadelphia‐negative’ myeloproliferative neoplasms (MPN‐AP/BP) diagnosed between 2013 and 2025. Median age at transformation was 71 years.
Alexandros Rampotas, Gabriel Naylor‐Layland, Clare Brown, Ahmad Alabdulkarim, Jennifer Ryan, Frances Wadelin, Samah Alimam, Phyo Wint Wint Tun, Jonathan Lambert, Jennifer O'Sullivan, Andrew J. Wilson, Laith Tafesh, Andrew McGregor, Simone Claudiani, Andrew Innes, Emily Booth, James Leveson, Steve Knapper, Mamta Garg, Mani Dubey, Theodora Vatopoulou, Charlotte Brierley, Wai Ka Natalie Leung, Graham Greenfield, Mary Frances McMullin, Alesia Khan, Kate Milne, Duncan Brian, Anna Godfrey, Claire N. Harrison, Bethan Psaila, Patrick Harrington, Amy Kirkwood, Tim C. P. Somervaille, Donal P. McLornan, on behalf of the UK Blood Cancer Research Network MPN Clinical Study Group   +35 more
wiley   +1 more source